Is It Time To Rethink IDEXX Laboratories (IDXX) After Its Recent Share Price Swings
- Wondering whether IDEXX Laboratories at around US$577 per share is priced for perfection or still leaves room on the table, this article focuses squarely on what that current price might imply about value.
- The stock has had a mixed stretch recently, with a 3.7% gain over the last 7 days, a 5.1% decline over the past 30 days, and a 13.8% decline year to date, while still showing a 52.4% return over the last year and 21.0% and 14.0% annualized over 3 and 5 years.
- Recent price moves are occurring against an evergreen backdrop, where investors are revisiting long term compounders and reassessing what they are prepared to pay for quality healthcare names. For IDEXX, this means current valuations are being weighed more carefully against…
Source link
